6.
Seker F, Qureshi M, Mohlenbruch M, Nogueira R, Abdalkader M, Ribo M
. Reperfusion Without Functional Independence in Late Presentation of Stroke With Large Vessel Occlusion. Stroke. 2022; 53(12):3594-3604.
DOI: 10.1161/STROKEAHA.122.039476.
View
7.
Olthuis S, Pirson F, Pinckaers F, Hinsenveld W, Nieboer D, Ceulemans A
. Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled,.... Lancet. 2023; 401(10385):1371-1380.
DOI: 10.1016/S0140-6736(23)00575-5.
View
8.
Mitchell P, Yan B, Churilov L, Dowling R, Bush S, Bivard A
. Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial. Lancet. 2022; 400(10346):116-125.
DOI: 10.1016/S0140-6736(22)00564-5.
View
9.
Bai Y, Li Y, Tang Z, Hu L, Jiang X, Chen J
. Urinary proteome analysis of acute kidney injury in post-cardiac surgery patients using enrichment materials with high-resolution mass spectrometry. Front Bioeng Biotechnol. 2022; 10:1002853.
PMC: 9513377.
DOI: 10.3389/fbioe.2022.1002853.
View
10.
Ahmad M, Dar N, Bhat Z, Hussain A, Shah A, Liu H
. Inflammation in ischemic stroke: mechanisms, consequences and possible drug targets. CNS Neurol Disord Drug Targets. 2014; 13(8):1378-96.
DOI: 10.2174/1871527313666141023094720.
View
11.
Warach S, Johnston S
. Endovascular Thrombectomy for Ischemic Stroke: The Second Quantum Leap in Stroke Systems of Care?. JAMA. 2016; 316(12):1265-6.
DOI: 10.1001/jama.2016.12266.
View
12.
Goyal M, Menon B, van Zwam W, Dippel D, Mitchell P, Demchuk A
. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016; 387(10029):1723-31.
DOI: 10.1016/S0140-6736(16)00163-X.
View
13.
Saver J, Goyal M, van der Lugt A, Menon B, Majoie C, Dippel D
. Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. JAMA. 2016; 316(12):1279-88.
DOI: 10.1001/jama.2016.13647.
View
14.
Zang N, Lin Z, Huang K, Pan Y, Wu Y, Wu Y
. Biomarkers of Unfavorable Outcome in Acute Ischemic Stroke Patients with Successful Recanalization by Endovascular Thrombectomy. Cerebrovasc Dis. 2020; 49(6):583-592.
DOI: 10.1159/000510804.
View
15.
Haarmann A, Vollmuth C, Kollikowski A, Heuschmann P, Pham M, Stoll G
. Vasoactive Soluble Endoglin: A Novel Biomarker Indicative of Reperfusion after Cerebral Large-Vessel Occlusion. Cells. 2023; 12(2).
PMC: 9856463.
DOI: 10.3390/cells12020288.
View
16.
Li Y, Wang Y, Zou W
. Exploration on the Mechanism of Ubiquitin Proteasome System in Cerebral Stroke. Front Aging Neurosci. 2022; 14:814463.
PMC: 9022456.
DOI: 10.3389/fnagi.2022.814463.
View
17.
Deng G, Xiao J, Yu H, Chen M, Shang K, Qin C
. Predictors of futile recanalization after endovascular treatment in acute ischemic stroke: a meta-analysis. J Neurointerv Surg. 2021; 14(9):881-885.
DOI: 10.1136/neurintsurg-2021-017963.
View
18.
Uniken Venema S, Postma A, van den Wijngaard I, Vos J, Lingsma H, Bokkers R
. White Matter Lesions and Outcomes After Endovascular Treatment for Acute Ischemic Stroke: MR CLEAN Registry Results. Stroke. 2021; 52(9):2849-2857.
PMC: 8378429.
DOI: 10.1161/STROKEAHA.120.033334.
View
19.
Ma X, Ding W, Wang J, Wu G, Zhang H, Yin J
. LOC66273 isoform 2, a novel protein highly expressed in white adipose tissue, induces adipogenesis in 3T3-L1 cells. J Nutr. 2012; 142(3):448-55.
DOI: 10.3945/jn.111.152108.
View
20.
Hao J, Feng Y, Xu X, Li L, Yang K, Dai G
. Plasma Lipid Mediators Associate With Clinical Outcome After Successful Endovascular Thrombectomy in Patients With Acute Ischemic Stroke. Front Immunol. 2022; 13:917974.
PMC: 9295711.
DOI: 10.3389/fimmu.2022.917974.
View